Nontransplant alternatives for the treatment of patients with metabolic disease

Seminars in Liver Disease

Volumn 18, Issue 3, 1998, Pages 255-261

  A Kader, Hassan Hesham ^a   Balistreri, William F ^b  

^a STATE UNIVERSITY OF NEW YORK   (United States)

^b CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

Author keywords

Hemochromatosis; Metabolic; Nontransplant; Tyroninemia

Indexed keywords

2 (2 NITRO 4 TRIFLUOROMETHYLBENZOYL) 1,3 CYCLOHEXADEDIONE; 3(OR 17)BETA HYDROXYSTEROID DEHYDROGENASE; 4 HYDROXYPHENYLPYRUVATE DIOXYGENASE; ACETYLCYSTEINE; ANTIOXIDANT; BILE ACID; CHENODEOXYCHOLIC ACID; CHOLIC ACID; DEFEROXAMINE; ENZYME INHIBITOR; FUMARYLACETOACETASE; PROSTAGLANDIN E1; STEROID 5BETA REDUCTASE; TOCOFERSOLAN; UNCLASSIFIED DRUG;

BILE ACID SYNTHESIS; BILIARY TRACT DISEASE; CLINICAL FEATURE; CLINICAL TRIAL; ENZYME DEFICIENCY; HEMOCHROMATOSIS; HUMAN; LIVER DISEASE; LIVER TRANSPLANTATION; METABOLIC DISORDER; PRIORITY JOURNAL; REVIEW; TYROSINEMIA;

EID: 0031718357     PISSN: 02728087     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-1007161     Document Type: Review

References (38)

1. A-Kader HH, Ryckman FC, Balistreri WF. Liver transplantation in the pediatric population: Indications and monitoring. Clin Transplant 1991;5:161-167
2. Kilpe VE, Krakauer H, Wren RE. An analysis of liver transplant experience from 37 transplant centers as reported to Medicare. Transplantation 1993;56.554-561
3. Balistreri WF. Non-transplant options for the treatment of metabolic liver disease-saving livers while saving lives. Hepatology 1994;19 782-787
4. Balistreri WF. Inborn errors of bile acid metabolism: Clinical and therapeutic aspects In: Hofmann AF, Paumgartener G, Stiehl A, (eds.): Bile acids in gastroenterology: Basic and clinical advances. London, Kluwer Academic Publishers, 1995, pp 333-353
5. 4-oxosteroid 5ß reductase deficiency described in identical twins with neonatal hepatitis A new inborn error in bile acid synthesis. J Clin Invest 1988;82:2135-2146
6. Clayton PT, Leonard JV, Lawson AM, et al. Familial giant cell hepatitis associated with synthesis of 3, 7, 12 trihydroxy-5-cholenoic acids. J Clin Invest 1987;79:1031-1036
7. 27-steroid dehydrogenase/isomerase deficiency. J Pediatr 1994; 125:379-384
8. Setchell KDR, O' Connell NC. Inborn errors of bile acid biosynthesis: Update on biochemical aspects. In. Hofmann AF, Paumgartner G, Stiehl A, (eds): Bile acids in gastroenterology: Basic and clinical advances. London, Kluwer Academic Publishers, 1995, pp 129-136
9. 4-oxosteroid 5ß reductase deficiency). Hepatology 1993;18:1096-1101
10. Paradis K et al. Tyrosinemia. Chap. 45. In: Suchy FJ, (ed). Liver disease in children, 1st edition. St. Louis, Mosby-Yearbook Inc. 1994:803-818
11. Lindblad B, Lindstedt L, Steen G, et al., The enzyme defect in hereditary tyrosinemia. Proc Natl Acad Sci USA 1977;4641-4645
12. Mitchell G, Larochelle J, Lambert M, et al. Neurologic crisis in hereditary tyrosinemia. N Engl J Med 1990;322:432-437
13. Grompe M, St-Louis M, Demers SI, et al. A single mutation of the fumarylacetoacetate hydrolase gene in French Canadians with hereditary tyrosinemia type I. N Engl J Med 1994;331:353-357
14. Van Spronsen FJ, Thomasse Y, Smith GPA, et al. Hereditary tyrosinemia: A new clinical classification with difference in prognosis on dietary treatment. Hepatology 1994;25:1187-1195
15. Weinberg AG, Mizc CE, Worthen HG. The occurrence of hepatoma in the chronic form of hereditary tyrosinemia. J Pediatr 1976;88:434-439
16. Paradis K, Weber A, Seidman EG, et al. Liver transplantation for hereditary tyrosinemia. The classic Quebec experience. Am J Hum Genet 1990;47:338-343
17. Ploos Van Amstiel JK, Jensen RPM, Van DenBerg IET, et al. Prenatal diagnosis of type I hereditary tyrosinemia. Lancet 1994; 344:336-338
18. Mieles LA, Esquivel CO, Van Thiel DH, et al. Liver transplantation for tyrosinemia: A review of 10 cases from the University of Pittsburgh. Dig Dis Sci 1990;35:153-157
19. Shoemaker LR, Strife CF, Balistreri WF, Ryckman FG. Rapid improvement in the renal tubular dysfunction associated with tyrosinemia following hepatic replacement. Pediatrics 1992;89: 251-255
20. Lindstedt S, Holme E, Locke A, et al. Treatment of hereditary tyrosinemia Type I by inhibition of 4-hydroxyphenylpyruvate dioxygenase. Lancet 1992;340:813-818
21. Klebig ML, Russell LB, Rinchik EM. Murine fumarylacetoacetate hydrolase (FAH) gene is disrupted by a neonatally lethal albino deletion that defines the hepatocyte-specific development regulation 1 (HSDR-1) locus. Proc Natl Acad Sci USA 1992;89: 1363-1367
22. Knisely AS. Neonatal hemochromatosis. Adv Pediatr 1992;39: 383-403
23. Hoogstraten DJ, Knisely AS. Fetal liver disease may precede extra-hepatic siderosis in neonatal hemochromatosis. Gastroenterology 1990;98:1699-1701
24. Rand EB, McClenathan DT, Whitington PF. Neonatal hemochromatosis; report of successful orthotopic liver transplantation. J Pediatr Gastroenterol Nutr 1992;15;325-329
25. Westerhausen M, Meuret G. Transferrin-immune complex disease. Acta Haematol 1977;527:96-101
26. Barnard JA, Mancia E. Idiopathic neonatal hemochromatosis with survival. J Pediatr Gastroenterol Nutr 1980;7:39-45
27. Knisley AS, O'Shea PA, Stocks JF, Dimmick JE Orophayngeal and upper respiratory mucosal-gland siderosis in neonatal hemochromatosis: An approach to biopsy diagnosis. J Pediatr 1988;113:871-874
28. Hayes AM, Jaramillo D, Levy H, et al. Neonatal hemochromatosis: Diagnosis with MRI imaging. Am J Radiol 1992;159:623-625
29. Marti-Bonmati L, Baamonde A, Poyatos CR, Monteagudo E. Prenatal diagnosis of idiopathic neonatal hemochromatosis. Abdom Imaging 1994;19:55-56
30. Rand JB, McClenathan DT, Whittington PF. Neonatal hemochromatosis: Report of a successful orthotopic liver transplantation. J Pediatr Gastroenterol Nutr 1992;15;325-330
31. Lund DP, Lilleheicw, Kevy S, et al. Liver transplantation in newborn liver failure: Report of successful liver transplantation. Transplant Proc 1993;25:1068
32. Shamieh I, Kibort PK, Suchy FJ, et al. Antioxidant therapy for neonatal iron storage disease (NISD). Pediatr Res 1993;33:109a
33. Sigurdsson L, Reyes J, Kocoshis SA, et al. Neonatal hemochromatosis: Outcomes of Pharmacological and Surgical Therapies. J Pediatr Gastroenterol Nutr 1998;26:85-89
34. Ledley FD. Somatic gene therapy in gastroenterology: Approaches and applications. J Pediatr Gastroenterol Nutr 1992;14: 328-337
35. Wilson JM, Chowdhury NR, Grossman M, et al. Temporary amelioration of hyperlipidemia in low-density lipoprotein receptor-deficient rabbits transplanted with genetically modified hepatocytes Proc Natl Acad Sci USA 1990;87:8437-8441
36. Makdisi WJ, Wu CH, Wu GY. Methods of gene transfer into hepatocytes: Progress towards gene therapy. In: Boyer JL, Ockner RK, (eds): Progress in liver diseases. Philadelphia, W B Saunders, 1992, pp 1-24
37. Sandig V, Hofmann C, Loser P, et al. Gene therapy: prospects for treatment of liver disease. Gastroenterology 1996;30:25-26
38. Sandig V, Hofmann C, Steinert S, et al. Gene transfer into hepatocytes and human liver tissue by Baculovirus vectors. Hum Gene Ther 1996;1937-1945